Mike Trower
Gründer bei NeRRe Therapeutics Ltd.
Aktive Positionen von Mike Trower
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
NeRRe Therapeutics Ltd.
 NeRRe Therapeutics Ltd. Medical DistributorsDistribution Services NeRRe Therapeutics Ltd. provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity. It develops neurokinin receptor antagonists acquired from GlaxoSmithKline. The company was founded by Emiliangelo Ratti and Mike Trower in 2012 and is headquartered in Stevenage, the United Kingdom. | Direktor/Vorstandsmitglied | 01.12.2012 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 01.12.2012 | - | |
| Gründer | 01.12.2012 | - |
Karriereverlauf von Mike Trower
Ehemalige bekannte Positionen von Mike Trower
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
KaNDy Therapeutics Ltd.
 KaNDy Therapeutics Ltd. BiotechnologyHealth Technology KaNDy Therapeutics Ltd. engages in the provision of a treatment of chronic debilitating female sex-hormone related conditions. Its product is NT-814 a non-hormonal therapy to treat moderate to severe post-menopausal vasomotor symptoms. The company was founded by Dr. Mike Trower and Mary Kerr in 2017 and is headquartered in Stevenage, the United Kingdom. | Geschäftsführer | 01.01.2017 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2017 | - | |
| Gründer | 01.01.2017 | - |
Statistik
International
| Vereinigtes Königreich | 3 |
Operativ
| Founder | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Director/Board Member | 1 |
Sektoral
| Distribution Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
NeRRe Therapeutics Ltd.
NeRRe Therapeutics Ltd. Medical DistributorsDistribution Services NeRRe Therapeutics Ltd. provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity. It develops neurokinin receptor antagonists acquired from GlaxoSmithKline. The company was founded by Emiliangelo Ratti and Mike Trower in 2012 and is headquartered in Stevenage, the United Kingdom. | Distribution Services |
KaNDy Therapeutics Ltd.
KaNDy Therapeutics Ltd. BiotechnologyHealth Technology KaNDy Therapeutics Ltd. engages in the provision of a treatment of chronic debilitating female sex-hormone related conditions. Its product is NT-814 a non-hormonal therapy to treat moderate to severe post-menopausal vasomotor symptoms. The company was founded by Dr. Mike Trower and Mary Kerr in 2017 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Mike Trower
- Erfahrung
